New meningitis vaccine shows promise in vietnam trial
NCT ID NCT06228586
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study tested a single dose of an investigational meningitis vaccine (MenACYW) in 447 healthy people aged 12 months and older in Vietnam. The goal was to see how well the vaccine triggered the body's defenses against four types of meningococcal bacteria and to check for any side effects. Results showed the vaccine produced a strong immune response and was generally safe, with most side effects being mild and temporary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number : 7040001
Hanoi, Vietnam
-
Investigational Site Number : 7040002
Thái Bình, 410000, Vietnam
-
Investigational Site Number : 7040003
Thái Bình, 70000, Vietnam
-
Investigational Site Number : 7040004
Thái Bình, 70000, Vietnam
Conditions
Explore the condition pages connected to this study.